Singular Genomics Systems (NASDAQ:OMIC) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.41) by 19.51 percent. This is a 32 percent decrease over losses of $(0.25) per share from the same period last year.
Piper Sandler Maintains Overweight on Delek US Hldgs, Lowers Price Target to $46
Piper Sandler analyst Ryan Todd maintains Delek US Hldgs (NYSE:DK) with a Overweight and lowers the price target from $47 to $46.